Phenylpropropanolamine Hcl

Verify with FDA CVM →

956 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
956
Total Reports
50
Deaths Reported
520.0%
Death Rate

Active Ingredients

Phenylpropropanolamine Hcl

Administration Routes

OralUnknownTopical

Species Affected

Dog 753
Unknown 195
Human 4
Cat 2
Horse 1
Other 1

Most Affected Breeds

Unknown 201
Retriever - Labrador 131
Shepherd Dog - German 52
Crossbred Canine/dog 40
Boxer (German Boxer) 35
Pit Bull 32
Dog (unknown) 30
Doberman Pinscher 24
Siberian Husky 23
Retriever - Golden 17

Most Reported Reactions

Vomiting 135
Overdose 133
Underdose 131
Tablets, Abnormal 129
Lack of efficacy - NOS 121
Panting 94
Emesis (multiple) 77
Lethargy (see also Central nervous system depression in 'Neurological') 68
Accidental exposure 53
Agitation 53
INEFFECTIVE, OTHER DRUG(S) 51
Behavioural disorder NOS 47

Outcome Breakdown

Recovered/Normal
312 (41.0%)
Outcome Unknown
310 (40.7%)
Ongoing
76 (10.0%)
Euthanized
28 (3.7%)
Died
22 (2.9%)
Recovered with Sequela
13 (1.7%)

Data Summary

Metric Value
Total adverse event reports 956
Reports involving death 50
Case-fatality rate (reported events) 520.0%
Distinct species in reports 6
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Phenylpropropanolamine Hcl Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 956 adverse event reports referencing Phenylpropropanolamine Hcl, including 50 reports in which the animal died — a 520.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Phenylpropropanolamine Hcl. Reported administration routes include Oral, Unknown, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Phenylpropropanolamine Hcl reports are Dog (753 reports), Unknown (195 reports), Human (4 reports), with Dog accounting for the largest share. Within those species, Unknown (201), Retriever - Labrador (131), Shepherd Dog - German (52) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Phenylpropropanolamine Hcl are Vomiting (135), Overdose (133), Underdose (131), Tablets, Abnormal (129). Of the 761 reports with a coded outcome, Recovered/Normal is the leading category at 41.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Phenylpropropanolamine Hcl.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial